Znanstveni rad - Prikaz slučaja
Bullous Sweet syndrome following SARS‐CoV‐2 Oxford AstraZeneca vaccine
British Journal of Dermatology, 186 (2021), 3; 110. https://doi.org/10.1111/bjd.20876


Povezani objekti
COVID-19 | Virtualna zbirka
Citirajte ovaj rad

Žagar, T., Hlača, N., Brajac, I., Prpić‐Massari, L., Peternel, S. i Kaštelan, M. (2021). Bullous Sweet syndrome following SARS‐CoV‐2 Oxford AstraZeneca vaccine. British Journal of Dermatology, 186. (3). doi: 10.1111/bjd.20876

Žagar, Tina, et al. "Bullous Sweet syndrome following SARS‐CoV‐2 Oxford AstraZeneca vaccine." British Journal of Dermatology, vol. 186, br. 3, 2021. https://doi.org/10.1111/bjd.20876

Žagar, Tina, Nika Hlača, Ines Brajac, Larisa Prpić‐Massari, Sandra Peternel i Marija Kaštelan. "Bullous Sweet syndrome following SARS‐CoV‐2 Oxford AstraZeneca vaccine." British Journal of Dermatology 186, br. 3 (2021). https://doi.org/10.1111/bjd.20876

Žagar, T., et al. (2021) 'Bullous Sweet syndrome following SARS‐CoV‐2 Oxford AstraZeneca vaccine', British Journal of Dermatology, 186(3). doi: 10.1111/bjd.20876

Žagar T, Hlača N, Brajac I, Prpić‐Massari L, Peternel S, Kaštelan M. Bullous Sweet syndrome following SARS‐CoV‐2 Oxford AstraZeneca vaccine. British Journal of Dermatology [Internet]. 24.11.2021. [pristupljeno 14.04.2024.];186(3). doi: 10.1111/bjd.20876

T. Žagar, N. Hlača, I. Brajac, L. Prpić‐Massari, S. Peternel i M. Kaštelan, "Bullous Sweet syndrome following SARS‐CoV‐2 Oxford AstraZeneca vaccine", British Journal of Dermatology, vol. 186, br. 3, Studeni 2021. [Online]. Dostupno na: https://urn.nsk.hr/urn:nbn:hr:184:079713. [Citirano: 14.04.2024.]

Prijavite se u repozitorij kako biste mogli spremiti objekt u svoju listu.